Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: a randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU)

Raja Dhar, John Kirkpatrick, Laura Gilbert, Arjun Khanna, Mahavir Madhavdas Modi, Rakesh K. Chawla, Sonia Dalal, Venkata Nagarjuna Maturu, Marcel Stern, Oliver Keppler, Ratko Djukanović, Stephan Gadola
doi: https://doi.org/10.1101/2022.01.30.22269685

Data Availability

All data produced are available online at GitHub the following data repository: https://github.com/PuzzledFace/DoxyICU_Results

https://github.com/PuzzledFace/DoxyICU_Results

Back to top
Posted February 22, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: a randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU)
Raja Dhar, John Kirkpatrick, Laura Gilbert, Arjun Khanna, Mahavir Madhavdas Modi, Rakesh K. Chawla, Sonia Dalal, Venkata Nagarjuna Maturu, Marcel Stern, Oliver Keppler, Ratko Djukanović, Stephan Gadola
medRxiv 2022.01.30.22269685; doi: https://doi.org/10.1101/2022.01.30.22269685
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area